Clinical trials
Phase 1 Huntington Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 10 |
| 2011 | 1 |
| 2018 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 8 |
| Institute for Neurodegenerative Disorders | 2 |
| University of Rochester | 2 |
| Georgetown University | 1 |
| Hoffmann-La Roche | 1 |
| Oregon Health and Science University | 1 |
| Siena Biotech S.p.A. | 1 |
| Supernus Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huntington Disease | 17 |
| Alzheimer Disease | 9 |
| Chorea | 2 |
| Parkinson Disease | 2 |
| Autism Spectrum Disorder | 1 |
| Basal Ganglia Diseases | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cognition Disorders | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.